SCHEMBL13340263

SCHEMBL13340263

c1ccc(-c2ccc(-c3cc(-c4ccccc4)c4c5ccccc5c5ccccc5c4c3-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
ALDH1A1 P00352 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
GPR84 Q9NQS5 2/20 0.32
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
ACHE P22303 2/20 0.31
ATM Q13315 2/20 0.30
USP2 O75604 1/20 0.30
MAPK1 P28482 1/20 0.30
CTNNB1 P35222 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
ADK P55263 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13340231 0.98 MAPT (0.35) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL11961244 0.98 MAPT (0.35) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL13340271 0.98 MAPT (0.35) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL13340306 0.98 MAPT (0.35) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL13340348 0.94 MAPT (0.32) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL13339763 0.94 MAPT (0.32) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL13339977 0.94 MAPT (0.32) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL13340350 0.94 MAPT (0.32) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL13340147 0.94 MAPT (0.32) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL13339836 0.94 MAPT (0.32) MAPTALDH1A1L3MBTL1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 MAPT 3478/4885ALDH1A1 428/4885L3MBTL1 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.